Literature DB >> 3816421

Cartilage proteoglycans.

T E Hardingham, M Beardmore-Gray, D G Dunham, A Ratcliffe.   

Abstract

The structure of the protein core of the high molecular weight aggregating proteoglycan from pig laryngeal cartilage has been investigated. Mild trypsin digestion of proteoglycan aggregates released a large (Mr approximately equal to 150K) protein-rich fragment that contained the hyaluronate-binding region (Mr 66K). Rotary-shadowing electron microscopy of this preparation showed it to contain 'double globe' structures, similar to those seen with intact proteoglycans. Interaction studies and immunochemical evidence showed that one of the globular domains was the binding region. The second globular domain did not interact with hyaluronate or share any major antigenic determinants with the binding region and its function remains unknown. Further evidence from rotary shadowing also suggested that the protein core contained a third globular domain at the C-terminal end. The complete protein core sequence thus contains long folded globular protein regions, in addition to the extended regions bearing glycosaminoglycan chains. Studies of proteoglycan turnover in explants of pig articular cartilage showed that proteoglycan fragments were continuously released into the medium during culture. These included large non-aggregating proteoglycan fragments, free binding region and also link protein. Proteoglycans retained within the cartilage matrix remained intact and able to aggregate. Only in the presence of interleukin 1 was there evidence of more extensive proteolytic digestion. The results suggest normal turnover to be a conservative mechanism involving the selective cleavage of proteoglycan close to the hyaluronate-binding region. This releases the major glycosaminoglycan-bearing domain and enables it to diffuse out of the matrix. The site of the initial cleavage appears to be in the region of the N-terminal globular domains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816421     DOI: 10.1002/9780470513385.ch3

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  8 in total

1.  The detection of substructures within proteoglycan molecules. Electron-microscopic immuno-localization with the use of Protein A-gold.

Authors:  J K Sheehan; A Ratcliffe; K Oates; T E Hardingham
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

2.  Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease.

Authors:  A Ratcliffe; M Doherty; R N Maini; T E Hardingham
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

3.  Cartilage proteoglycans. Assembly with hyaluronate and link protein as studied by electron microscopy.

Authors:  M Mörgelin; M Paulsson; T E Hardingham; D Heinegård; J Engel
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

Review 4.  Cytokines and proteoglycans.

Authors:  J J Nietfeld
Journal:  Experientia       Date:  1993-05-15

5.  Methylprednisolone acetate induced release of cartilage proteoglycans: determination by high performance liquid chromatography.

Authors:  H Saari; R M Tulamo; Y T Konttinen; T Sorsa
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

6.  Isolation of the N-terminal globular protein domains from cartilage proteoglycans. Identification of G2 domain and its lack of interaction with hyaluronate and link protein.

Authors:  A J Fosang; T E Hardingham
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

7.  Axial electron density of human scleral collagen. Location of proteoglycans by x-ray diffraction.

Authors:  A J Quantock; K M Meek
Journal:  Biophys J       Date:  1988-07       Impact factor: 4.033

8.  Extended and globular protein domains in cartilage proteoglycans.

Authors:  M Paulsson; M Mörgelin; H Wiedemann; M Beardmore-Gray; D Dunham; T Hardingham; D Heinegård; R Timpl; J Engel
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.